The Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market is characterized by extremely high therapeutic costs, making pharmacoeconomic analysis—the study of cost-effectiveness—critical for healthcare systems. The choice between delivery methods for Immunoglobulin (Ig) is a major cost driver. Ig as the Primary Cost Driver: For both Intravenous Immunoglobulin (IVIG)...